July 1, 2016
Uncertainties in the healthcare market can increase volatility in investment projections, which impacts financial incentives for investors. Greater risk is associated with financing research and development, given the need to clear clinical and regulatory hurdles before receiving approval and going to market. In addition, with each new stage in development, investors must...
Read on »